Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 30 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 10100317

    Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  2. US 10093664

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  3. US 10092593

    Citrate-rich calcium-magnesium supplement and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  4. US 10092512

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

  5. US 10087444

    MicroRNA composition for the treatment of neuroblastoma

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  6. US 10086091

    Method of preparation of biodegradable nanoparticles with recognition characteristics

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  7. US 10086041

    Syndecan-4 proteoliposomes for enhanced cutaneous wound healing and minimized inflammatory immune response

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  8. US 10086114

    Antimicrobial solutions with enhanced stability

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  9. US 10082496

    Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  10. US 10080774

    Oncolytic adenovirus armed with therapeutic genes

    The Board of Regents of the University of Texas System · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  11. US 10076562

    Methods for treating plague

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  12. US 10076538

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  13. US 10076509

    Nested particles and the use thereof for coordinated delvery of active agents

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  14. US 10072022

    Oridonin analogs, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  15. US 10072062

    Methods and compositions for modification of a HLA locus

    The Board of Regents of the University of Texas System · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  16. US 10064942

    Copper-cysteamine and methods of use

    The Board of Regents of the University of Texas System · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  17. US 10035846

    Humanized pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  18. US 10023637

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  19. US 10022385

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  20. US 10018638

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  21. US 10017598

    Block copolymer and micelle compositions and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  22. US 10010534

    Intravenous formulation and LC/MS/MS analysis method for GMC1

    The Board of Regents of the University of Texas System · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  23. US 10011589

    Treatments for gastrointestinal conditions

    The Board of Regents of the University of Texas System · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  24. US 10012653

    Nanoparticles for targeting acid tumor microenvironments

    The Board of Regents of the University of Texas System · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.